# ROLE OF URINARY BIOMARKER NEUTROPHIL GELATINASE ASSOCIATED LIPOCALCIN (NGAL) IN EARLY PREDICTION OF AKI IN CIRRHOSIS OF LIVER

> **NCT05161910** · — · COMPLETED · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 120 (actual)

## Conditions studied

- Renal Failure

## Interventions

- **OTHER:** Biomarkers

## Key facts

- **NCT ID:** NCT05161910
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-08-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161910, "ROLE OF URINARY BIOMARKER NEUTROPHIL GELATINASE ASSOCIATED LIPOCALCIN (NGAL) IN EARLY PREDICTION OF AKI IN CIRRHOSIS OF LIVER". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05161910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*